Mostra i principali dati dell'item
Mortality of intubated patients with COVID-19 during first and subsequent waves: a meta-analysis involving 363,660 patients from 43 countries
dc.creator | Xourgia E., Katsaros D.E., Xixi N.A., Tsolaki V., Routsi C., Zakynthinos S.G., Kotanidou A., Siempos I.I. | en |
dc.date.accessioned | 2023-01-31T11:37:44Z | |
dc.date.available | 2023-01-31T11:37:44Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1080/17476348.2022.2145950 | |
dc.identifier.issn | 17476348 | |
dc.identifier.uri | http://hdl.handle.net/11615/80858 | |
dc.description.abstract | Background: We attempted to investigate the change in mortality of intubated patients with coronavirus disease (COVID-19) from first to subsequent waves across several countries. Methods: We pre-registered our meta-analysis with PROSPERO [Anonymized]. We searched PubMed, Scopus, and gray literature for observational studies reporting data on all-cause mortality of intubated patients with COVID-19 recruited both during first and subsequent waves of the pandemic. We considered studies published after 31 August 2020 up to 12 July 2021. The primary outcome of the meta-analysis was all-cause mortality. We used a random effects model to calculate pooled risk ratio (RR) and 95% confidence intervals (CI). Results: By incorporating data of 363,660 patients from 43 countries included in 28 studies, we found that all-cause mortality of intubated patients with COVID-19 increased from first to subsequent waves (from 62.2% to 72.6%; RR 0.90, 95% CI 0.85–0.94, p < 0.00001). This finding was independent of the geo-economic variation of the included studies and persisted in several pre-specified subgroup and sensitivity analyses. Conclusions: The robust finding of this meta-analysis suggests that mortality of intubated patients with COVID-19 did not improve over time. Future research should target this group of patients to further optimize their management. © 2022 Informa UK Limited, trading as Taylor & Francis Group. | en |
dc.language.iso | en | en |
dc.source | Expert Review of Respiratory Medicine | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142233300&doi=10.1080%2f17476348.2022.2145950&partnerID=40&md5=4455aa9cf5259135206a250a4a7cc586 | |
dc.subject | acute respiratory failure | en |
dc.subject | adult | en |
dc.subject | adult respiratory distress syndrome | en |
dc.subject | all cause mortality | en |
dc.subject | Article | en |
dc.subject | artificial ventilation | en |
dc.subject | comorbidity | en |
dc.subject | coronavirus disease 2019 | en |
dc.subject | critically ill patient | en |
dc.subject | disease severity | en |
dc.subject | female | en |
dc.subject | human | en |
dc.subject | intensive care unit | en |
dc.subject | intubation | en |
dc.subject | length of stay | en |
dc.subject | male | en |
dc.subject | meta analysis | en |
dc.subject | mortality | en |
dc.subject | mortality rate | en |
dc.subject | pandemic | en |
dc.subject | renal replacement therapy | en |
dc.subject | systematic review | en |
dc.subject | vaccination | en |
dc.subject | vaccinee | en |
dc.subject | COVID-19 | en |
dc.subject | Humans | en |
dc.subject | Pandemics | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | Taylor and Francis Ltd. | en |
dc.title | Mortality of intubated patients with COVID-19 during first and subsequent waves: a meta-analysis involving 363,660 patients from 43 countries | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |